Hsp70 Inhibits Aminoglycoside-Induced Hair Cell Death and is Necessary for the Protective Effect of Heat Shock
- Mona TalebAffiliated withPathology and Laboratory Medicine, Medical University of South Carolina
- , Carlene S. BrandonAffiliated withPathology and Laboratory Medicine, Medical University of South Carolina
- , Fu-Shing LeeAffiliated withDepartment of Otolaryngology—Head and Neck Surgery, Medical University of South Carolina
- , Margaret I. LomaxAffiliated withKresge Hearing Research Institute and Department of Otolaryngology, University of Michigan
- , Wolfgang H. DillmannAffiliated withDepartment of Endocrinology, School of Medicine, University of California, San Diego
- , Lisa L. CunninghamAffiliated withPathology and Laboratory Medicine, Medical University of South Carolina Email author
Sensory hair cells of the inner ear are sensitive to death from aging, noise trauma, and ototoxic drugs. Ototoxic drugs include the aminoglycoside antibiotics and the antineoplastic agent cisplatin. Exposure to aminoglycosides results in hair cell death that is mediated by specific apoptotic proteins, including c-Jun N-terminal kinase (JNK) and caspases. Induction of heat shock proteins (Hsps) is a highly conserved stress response that can inhibit JNK- and caspase-dependent apoptosis in a variety of systems. We have previously shown that heat shock results in a robust upregulation of Hsps in the hair cells of the adult mouse utricle in vitro. In addition, heat shock results in significant inhibition of both cisplatin- and aminoglycoside-induced hair cell death. In our system, Hsp70 is the most strongly induced Hsp, which is upregulated over 250-fold at the level of mRNA 2 h after heat shock. Therefore, we have begun to examine the role of Hsp70 in mediating the protective effect of heat shock. To determine whether Hsp70 is necessary for the protective effect of heat shock against aminoglycoside-induced hair cell death, we utilized utricles from Hsp70.1/3 −/− mice. While heat shock inhibited gentamicin-induced hair cell death in wild-type utricles, utricles from Hsp70.1/3 −/− mice were not protected. In addition, we have examined the role of the major heat shock transcription factor, Hsf1, in mediating the protective effect of heat shock. Utricles from Hsf1 −/− mice and wild-type littermates were exposed to heat shock followed by gentamicin. The protective effect of heat shock on aminoglycoside-induced hair cell death was only observed in wild-type mice and not in Hsf1 −/− mice. To determine whether Hsp70 is sufficient to protect hair cells, we have utilized transgenic mice that constitutively overexpress Hsp70. Utricles from Hsp70-overexpressing mice and wild-type littermates were cultured in the presence of varying neomycin concentrations for 24 h. The Hsp70-overexpressing utricles were significantly protected against neomycin-induced hair cell death at moderate to high doses of neomycin. This protective effect was achieved without a heat shock. Taken together, these data indicate that Hsp70 and Hsf1 are each necessary for the protective effect of heat shock against aminoglycoside-induced death. Furthermore, overexpression of Hsp70 alone significantly inhibits aminoglycoside-induced hair cell death.
Keywordsototoxicity vestibular utricle Hsf1 knockout Hsp70 knockout Hsp70 overexpressor
In humans, hearing is the most commonly impaired sensory modality (Adams et al. 1999). One common cause of hearing loss involves the death of hair cells in the inner ear, which can be triggered by a number of stressors including noise trauma, drug toxicity, aging, and certain genetic conditions. In the US, hearing loss represents the sixth most prevalent chronic health problem (Adams et al. 1999). The high prevalence of this condition is related to the fact that, in contrast to hair cells of nonmammalian vertebrates, mammalian hair cells are not regenerated after they die.
Aminoglycoside antibiotics are among the ototoxic drugs that induce hair cell death in the inner ear. In recent years, significant progress has been made in characterizing aminoglycoside-induced hair cell death. Several studies show both molecular and morphological evidence that ototoxic hair cell death is apoptotic (Lang and Liu 1997; Forge and Li 2000; Cunningham et al. 2002; Matsui et al. 2002, 2003; Cheng et al. 2003; Mangiardi et al. 2004; Eshraghi et al. 2007). Aminoglycosides lead to the activation of caspases, and broad-spectrum caspase inhibitors suppress aminoglycoside-induced hair cell death (Cunningham et al. 2002; Matsui et al. 2002, 2003; Cheng et al. 2003; Tabuchi et al. 2007). In addition, in both the auditory and vestibular systems, inhibition of the JNK signaling pathway has been shown to protect hair cells against aminoglycoside-induced death (Pirvola et al. 2000; Ylikoski et al. 2002; Matsui et al. 2004; Sugahara et al. 2006; Eshraghi et al. 2007).
Heat shock proteins (Hsps) are induced in response to a wide variety of cellular and environmental stresses, including extreme temperatures, extreme ion concentrations, cellular energy depletion, and exposure to toxic substances. This induction of Hsps is a highly conserved stress response that serves to protect cells against subsequent cellular stresses, thus promoting cellular survival (Martindale and Holbrook 2002). The protective effect of Hsp upregulation may be attributed to the function of Hsps as protein chaperones. Hsps assist in the synthesis, assembly, folding, translocation, and degradation of proteins by ensuring appropriate protein conformation (Hartl 1996). However, Hsps can also inhibit apoptosis in a variety of systems by interfering with apoptotic signaling cascades. Hsp70 has been shown to inhibit JNK activation and cytochrome c release from the mitochondria (Mosser et al. 1997; Tsuchiya et al. 2003). In addition, Hsp70 and Hsp90 have both been shown to interfere with apoptosome formation required for caspase-9 activation (Beere et al. 2000; Li et al. 2000; Pandey et al. 2000; Saleh et al. 2000). Remarkably, Hsp70 has been shown to inhibit cell death even after downstream mediators, including caspase-3, have been activated (Jaattela et al. 1998).
We have previously demonstrated that heat shock, which strongly induces Hsp70 in the adult mouse utricle preparation, inhibits aminoglycoside-induced hair cell death (Cunningham and Brandon 2006). As mentioned above, there is evidence from other systems that Hsp70 can inhibit some of the same pathways that mediate aminoglycoside-induced hair cell death, including caspases and JNK. Therefore, we have examined the role of Hsp70 in the inhibition of aminoglycoside-induced hair cell death. Here, we have asked whether Hsp70 is necessary for the protective effect of heat shock against aminoglycoside-induced hair cell death and whether overexpression of Hsp70 is sufficient to protect hair cells against aminoglycoside-induced death. To address these questions, we utilized two lines of genetically modified mice, Hsp70.1/3 −/− mice and Hsp70-overexpressing mice, respectively (Marber et al. 1995; Hunt et al. 2004).
All mice were euthanized with an overdose of Nembutal (Abott Laboratories, USA) and decapitated. All animal protocols were approved by the MUSC Institutional Animal Care and Use Committee. All mice were maintained in the central animal care facility at the Medical University of South Carolina (Charleston, SC, USA).
Adult CBA/J mice (4 to 6 weeks old) were obtained from Harlan (Indianapolis, IN, USA).
Hsp70.1/3−/− mice were obtained from the Mutant Mouse Regional Resource Center at the University of California at Davis. In Hsp70.1/3−/− mice, both Hsp70.1 and Hsp70.3 genes have been inactivated by replacement of approximately 11 kb of genomic DNA on chromosome 17 with a NEO gene, which is under the control of an RNA polymerase II gene promoter (Hunt et al. 2004). Hsp70.1/3−/− mice are on the mixed genetic background B6;129S. Because Hsp70.1/3−/− mice are viable and fertile, litters were obtained by matings between knockout animals. B6129SF2/J mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA) and used as controls.
Hsp70-overexpressing mice constitutively express rat Hsp70 under the control of the human cytomegalovirus immediate early enhancer (hCMV-IE) and chicken β-actin promoter (Marber et al. 1995). These transgenic mice are on a BALB/c × C57BL/6 background. Male Hsp70-overexpressing mice were mated with wild-type female CB6F1 mice, which were obtained from the Jackson Laboratory. Resulting litters were approximately 50% wild-type (transgene negative; homozygous) and 50% Hsp70-overexpressing mice (transgene positive; heterozygous).
In Hsf1 −/− mice, a 1.8-kb genomic fragment has been replaced with a 2-kb NEO insert using a gene targeting vector for Hsf1 (McMillan et al. 1998). Hsf1 −/− mice, originally on the mixed genetic background C,129X1 (129X1/SvJ × BALB/c; McMillan et al. 1998), were crossed to CBA/CaJ. F1 progeny were tested for the A/G polymorphism in exon 7 of the Cdh23 gene. F1 mice containing the Cdh23 gene from CBA/CaJ were backcrossed to CBA/CaJ (The Jackson Laboratory) for at least four generations. Male heterozygous mice (Hsf1 +/− ) were mated with female heterozygous (Hsf1 +/− ) mice. In a total of 256 pups, there were 75 wild-types (Hsf1 +/+ ), 149 heterozygotes (Hsf1 +/− ), and 32 Hsf1-deficient (Hsf1 −/− ) mice. This corresponds to a 1:2:0.43 ratio, respectively, indicating that some prenatal lethality is observed in Hsf1 −/− mice on the CBA background. This is similar to reports on Hsf1−/− mice on the C,129-Hsf1 and R,129-Hsf1 backgrounds (Xiao et al. 1999).
Twenty-one days after birth, pups of transgenic and knockout strains were weaned and genotyped. Tail clips (1 mm) were lysed using DirectPCR Lysis Reagent (Tail; Viagen Biotech no. 101-T, Los Angeles, CA, USA). Crude DNA obtained from tail lysates was used in one-step polymerase chain reaction (PCR) genotyping (TaqMan Core Reagent Kit, Applied Biosystems no. N808-0228, Foster City, CA, USA; Mastercycler, Eppendorf no. 5333, Hamburg, Germany). The following primers were used:
Forward primer 5′-GAACGGAGGATAAAGTTAGG-3′, reverse primer 5′-ATGACACAGTGCCAAGACG-3′, yielding a 780-bp product of the inserted NEO gene.
Forward primer 5′-GTACACTTTAAACTCCCTCC-3′, reverse primer 5′-CTGCTTCTCTTGTCTTCG-3′, yielding a 454-bp product of the Hsp70 gene.
Forward primer 5′-ATTACGGGGTCATTAGTTCATAGCC-3′, reverse primer 5′-GTAGGAAAGTCCCATAAGGTCATGT-3′, yielding a 280-bp product of the CMV-IE region of the rat Hsp70 transgene.
Forward Hsf1 primer 5′-AGACCTGTCCTGTGTGCCTAGC-3′, reverse Hsf1 primer 5′-CAGTTCAACTGCCTACACAGACC-3′, yielding a 562-bp product of the Hsf1 gene; forward NEO primer 5′-AAGTATCCATCATGGCTGATGC-3′, reverse NEO primer 5′-TAGCCAACGCTATGTCCTGATA-3′, yielding a 339-bp product of the inserted NEO gene.
Mouse utricle organ culture
Adult mouse utricle dissections and culture conditions have previously been described in detail (Cunningham 2006). Briefly, adult mouse utricle dissections were performed under sterile conditions. Whole utricles with otoconia and stroma intact were cultured free-floating in a 24-well tissue culture plate (one to eight utricles per well). Each well contained 1 ml of culture medium, consisting of 2:1 (v/v) basal medium Eagle (Sigma, St. Louis, MO, USA) and Earle’s balanced salt solution (Invitrogen, Carlsbad, CA, USA), as well as 5% fetal bovine serum (FBS; Invitrogen), and 50 U/ml penicillin G (Sigma). Neomycin sulfate solution (Sigma) was supplied as a 10-mg/ml stock solution. Using culture medium, neomycin sulfate solutions were prepared at final concentrations ranging from 1 to 4 mM. Note: The dose–response curve in Figure 3 contains one data point (1 mM) that was previously published (Cunningham and Brandon 2006). Control utricles were cultured in the absence of neomycin. Gentamicin (Sigma) was supplied as a 51-mg/ml stock solution. Gentamicin solutions at final concentrations ranging from 2.5 to 25 mM were prepared using culture medium. Control utricles were cultured in culture medium only. Utricle cultures were maintained in an incubator at 37°C in a 5% CO2/95% air environment.
Heat shock protocol
The heat shock protocol has previously been described (Cunningham and Brandon 2006). Briefly, utricles were cultured overnight at 37°C before heat shock. For experiments involving heat shock, free-floating utricles and surrounding culture media were transferred from the 24-well tissue culture plate into sterile 1.5-ml microcentrifuge tubes. Tubes containing utricles to be heat shocked were placed into a water bath at 43°C for 30 min. Control utricles (no heat shock) were replaced in the incubator at 37°C. After the heat shock, all utricles were returned to the appropriate wells of the tissue culture plate and maintained in culture at 37°C for 6–30 h.
To allow for differential hair cell counts in the extrastriolar and striolar regions, utricles were processed for whole-mount, double-label fluorescent immunohistochemistry as previously described (Cunningham and Brandon 2006). Utricles were fixed in 4% paraformaldehyde overnight at 4°C. They were washed with phosphate-buffered saline (PBS) before otoconia removal. Otoconia were removed using either two pairs of no. 55 forceps (Fine Science Tools no. 11255-20, Foster City, CA, USA) or by a stream of phosphate-buffered saline using a syringe. For 3 h at room temperature, utricles were incubated in blocking solution (2% bovine serum albumin/0.8% normal goat serum/0.4% Triton-X in PBS). The following primary antibodies were diluted in blocking solution: monoclonal anti-calmodulin (Sigma no. C 3545; 1:150) and polyclonal anti-calbindin (Chemicon no. AB1778, Temecula, CA, USA; 1:200). Utricles were incubated in primary antibody solution at 4°C overnight, then washed with blocking solution. The following secondary antibodies were diluted in blocking solution: Alexa 488 conjugated goat anti-mouse IgG (Invitrogen no. A11001; 1:500) and Alexa 594 conjugated goat anti-rabbit IgG (Invitrogen no. A11012; 1:500). Utricles were incubated in secondary antibody solution for 4 h in the dark at room temperature on a rocking platform. They were washed and mounted on slides using Fluoromount-G (Southern Biotech, Birmingham, AL, USA). Utricles were visualized using a Zeiss Axioplan 2 fluorescent microscope and a high-resolution monochrome digital camera (Zeiss Axiocam MR). Using imaging software (Zeiss AxioVision), four striolar (calmodulin- and calbindin-positive) and four extrastriolar (calmodulin-positive, calbindin-negative), 900 μm2 (30 μm × 30 μm) areas were selected, and hair cells were counted in each square. Hair cells counts from the four extrastriolar and four striolar regions are averaged separately and reported as the striolar or extrastriolar hair cell density for each utricle.
Utricles to be sectioned were prepared according to Desai et al. (2005). Utricles were fixed with 4% paraformaldehyde with 1% picric acid (Sigma no. P6744), and 5% sucrose (Fisher no. S5-500, Pittsburgh, PA, USA) in 0.1 M Sorenson’s phosphate buffer (40 mM Na2HPO4/95 mM NaH2PO4; pH 7.4) (1× PB) for 1 h at room temperature. The fixative was removed, and utricles were placed in a 30% sucrose solution (in ddH2O). The tissue was microwaved in a water-chilled Pelco BioWave DFR-10 (Ted Pella, Inc., Redding, CA, USA) at 150 W for 2 min while maintaining a temperature below 21°C. Utricles were agitated overnight at 4°C in a 30% sucrose solution. They were treated with Cal-Ex (Fisher CS510–1D) for 30 s at room temperature to dissolve otoconia. Utricles were washed with 1× PB, then treated with a 1% sodium borohydride solution (Sigma no. S9125). Utricles were washed again and embedded in a solution consisting of 14% DifcoTM Gelatin (BD no. 214340, Sparks, MD, USA) and 30% sucrose. Frozen sections were cut at 35 μm thickness and placed in 1× PB. Sections were treated with 4% Triton X-100 in 1× PB (Sigma no. T-8787) for 1 h followed by blocking 1 h in 0.01 M PBS (1× PBS) with 0.5% fish gelatin (Sigma no. G7765), 1% BSA (Sigma no. A3294), and 0.5% Triton X-100. Primary antibodies were added: anti-Hsp70 (Stressgen no. SPA-810, Victoria, BC, Canada; 1:200), and anti-myosin VIIa (Proteus BioSciences Inc., Ramona, CA, USA). Sections were incubated with agitation overnight at 4°C. Sections were washed, then incubated for 2 h in Alexa 488 conjugated goat anti-mouse IgG (Invitrogen no. A11001; 1:500 in fish block) and Alexa 594-conjugated goat anti-rabbit IgG (Invitrogen no. A11012; 1:500 in fish block). After washing, Hoechst stain (1 μg/ml in 1× PBS) was applied for 30 s. The sections were washed with 1× PBS and mounted on glass slides using Fluoromount G (Southern Biotech). Sections were visualized using a Zeiss Axioplan 2 fluorescent microscope and a high-resolution monochrome digital camera (Zeiss Axiocam MR).
Western blot analysis
Utricles (12 per condition) were homogenized in cell lysis buffer (Epitomics no. 3500-1, Burlingame, CA, USA) supplemented with 1 mM phenylmethanesulphonylfluoride. Protein lysates were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using 4–15% Tris–HCl gels (Bio-Rad, Hercules, CA, USA), then transferred onto polyvinylidene fluoride (PVDF) membranes (Invitrogen). All primary antibodies were diluted in blocking solution, consisting of 0.2% I-Block (Tropix, Bedford, MA, USA), 0.1% TWEEN 20 (Sigma) in tris-buffered saline. Primary antibodies included anti-Hsp90 (Cell Signaling Technology no. 4874, Danvers, MA, USA; 1:1,000), anti-Hsp70 (Stressgen no. SPA-810; 1:1,000), anti-Hsp27 (Upstate no. 06-517, Lake Placid, NY, USA; 1:1,000), and anti-actin (Sigma no. A 2066; 1:1,000). Signal amplification and visualization were achieved using SuperSignal West Dura Extended Duration Substrate (Pierce Biotechnology no. 34075, Rockford, IL, USA). When probing the membrane for actin, ECL Plus Western Blotting Detection Reagents (GE Healthcare no. RPN2132, Piscataway, NJ, USA) were used for visualization.
Data were analyzed with either a one-way, two-way, or three-way analysis of variance (ANOVA) using statistical software SYSTAT 8.0 (San Jose, CA, USA). Post hoc tests were performed using pooled variances.
Heat shock induces Hsp70 in both hair cells and support cells
Protein levels of Hsp90, Hsp70, and Hsp27
Compared to controls, Hsp90 did not change significantly with heat shock in either utricles from CBA mice or those from the wild-type littermates of the Hsp70-overexpressing colony (Fig. 2). While Hsp90 mRNA levels were similar in utricles of Hsp70-overexpressing and wild-type utricles (data not shown), Hsp90 protein levels were lower in utricles of Hsp70-overexpressing mice than in those of their wild-type littermates (Fig. 2). Hsp27 expression was induced in response to heat shock in CBA and wild-type utricles compared to controls. In addition, Hsp27 levels were slightly increased in Hsp70-overexpressing utricles compared to those from wild-type littermates both at the mRNA level (data not shown) and at the protein level (Fig. 2).
Heat shock inhibits neomycin-induced hair cell death across the neomycin dose–response curve
Gentamicin kills utricular hair cells in a dose-dependent manner
Hsf1 is necessary for the protective effect of heat shock against aminoglycoside-induced hair cell death
Hsp70 is necessary for the protective effect of heat shock against aminoglycoside-induced hair cell death
Hsp70 overexpression inhibits neomycin-induced hair cell death
Hsp70 overexpression can account for much of the protective effect of heat shock
Hsp70 overexpression inhibits hair cell death at moderate to high doses of neomycin
The induction of Hsps is a highly conserved stress response that can promote cellular survival in response to a variety of stresses. We have previously demonstrated that heat shock, which leads to a robust induction of Hsp70, inhibits neomycin-induced hair cell death (Cunningham and Brandon 2006). Here, we have examined the roles of Hsf1 and Hsp70 in mediating the protective effect of heat shock. Our data indicate that Hsf1 and Hsp70 are both necessary for the protective effect of heat shock against aminoglycoside-induced hair cell death. In addition, we have shown that Hsp70 overexpression provides significant protection against aminoglycoside-induced hair cell death. In addition, Hsp70 overexpression can account for much of the protective effect of heat shock.
In sectioned utricles of CBA mice, we show that heat shock induces Hsp70 in both hair cells and support cells. Western blot analysis of Hsps revealed that heat shock leads to a robust upregulation of Hsp70 in CBA mice and in wild-type littermates of Hsp70-overexpressing mice. We show that heat shock-induced expression of Hsp70 is much more robust than the Hsp70 expression level achieved by constitutive overexpression of Hsp70 under the control of the human cytomegalovirus immediate early enhancer (hCMV-IE) and chicken β-actin promoter (Marber et al. 1995). In addition, Hsp27 is slightly upregulated in response to heat shock. Consistent with results at the mRNA level, there is slightly more Hsp27 in utricles of Hsp70-overexpressing mice than in those of their wild-type littermates. While there is no significant difference in Hsp90 mRNA levels, Hsp90 protein levels are decreased in Hsp70-overexpressing utricles compared to wild-type utricles. While Hsp70 has been shown to bind to the transactivation domain of Hsf1 to repress its transcriptional activity (Shi et al. 1998), this cannot explain the decreased Hsp90 protein levels, as we saw no difference in Hsp90 mRNA levels between Hsp70-overexpressing and wild-type utricles. These data suggest that Hsp90 regulation may undergo Hsp70-dependent posttranscriptional regulation. In addition, Hsp27 mRNA and protein levels are increased in Hsp70-overexpressing utricles compared to wild-type utricles, indicating that Hsp27 and Hsp90 expression are differentially regulated.
We previously published a dose–response curve for neomycin in the adult mouse utricle preparation in vitro (Cunningham et al. 2002). In addition, we showed that heat shock inhibits neomycin-induced hair cell death at a single dose of neomycin (1 mM; Cunningham and Brandon 2006). However, for a therapy to be potentially clinically useful, it must be protective against hair cell death across a range of neomycin doses. Therefore, we investigated whether heat shock is protective at higher neomycin concentrations. Our data indicate that heat shock provides significant protection against neomycin-induced hair cell death at both moderate and high doses of neomycin. This is in contrast to the protective effect of JNK inhibition on hair cell death which is only observed at moderate doses of neomycin (Sugahara et al. 2006). Thus, heat shock results in a robust protective effect against aminoglycoside-induced hair cell death.
Hsf1−/− mice were utilized to examine the role of Hsf1 in mediating the protective effect of heat shock against aminoglycoside-induced hair cell death. Hsf1 is the major transcription factor regulating the activation of inducible heat shock proteins. Stress-induced activation of Hsf1 involves trimerization, acquisition of DNA-binding activity, and translocation to the nucleus (Baler et al. 1993; Sarge et al. 1993). In the nucleus, Hsf1 binds to heat shock element (HSE) sequences present in the promoter regions of Hsps (Amin et al. 1988). In addition, regulation of Hsf1-mediated transcriptional activity is mediated by both constitutive and stress-inducible phosphorylation (Kline and Morimoto 1997; Holmberg et al. 2001, 2002; Guettouche et al. 2005). Hsf1−/− mice are viable but exhibit some degree of prenatal lethality and postnatal growth retardation (Xiao et al. 1999). In addition, Hsf1 is required for normal development of the placenta, and female Hsf1−/− mice are infertile (Xiao et al. 1999; Christians et al. 2000). Hsf1−/− mice are more susceptible to lipopolysaccharide-induced mortality, cadmium-induced pulmonary damage, and hydrochloric acid- or ethanol-induced gastric lesions (Xiao et al. 1999; Wirth et al. 2004; Tanaka et al. 2007). In the auditory system, Hsf1−/− mice demonstrate increased susceptibility to noise trauma (Sugahara et al. 2003; Fairfield et al. 2005). Our data indicate that the protective effect of heat shock on aminoglycoside-induced vestibular hair cell death requires Hsf1.
We have shown by Western blot analysis that heat shock robustly induces Hsp70. To determine whether the protective effect of heat shock against aminoglycoside-induced hair cell death requires Hsp70, we utilized Hsp70.1/3 −/− mice. These mice are double knockouts of Hsp70.1 and Hsp70.3. The locus of the Hsp70.2 gene is intact, however, Hsp70.2 is only expressed in spermatogenic cells (Zakeri et al. 1988). Hunt et al. (2004) demonstrated increased mutations in these mice in response to irradiation, suggesting that Hsp70 plays an important role in the maintenance of genomic stability. In addition, Hsp70.1/3 −/− mice demonstrate increased susceptibility to ischemia-induced damage to the heart and to acetaminophen-induced hepatotoxicity (Kim et al. 2006; Tolson et al. 2006). We examined the response to heat shock in Hsp70.1/3 −/− mouse utricles and found that Hsp70 is necessary for the protective effect provided by heat shock against aminoglycoside-induced hair cell death.
Heat stress has been shown to be protective against a number of insults in various systems. For example, short-term total body heat-stress has been shown to prevent light-induced damage to the photoreceptors in the retina, ischemia-induced death of hippocampal neurons and cardiac myocytes, carbon tetrachloride-induced hepatotoxicity, and lipopolysaccharide-induced pulmonary fibrosis (Barbe et al. 1988; Chopp et al. 1989; Marber et al. 1993; Lee et al. 2004; Hagiwara et al. 2007). In the auditory system, total body heat stress is protective against noise-induced hearing loss (Yoshida et al. 1999). Heat shock results in robust protection against aminoglycoside-induced hair cell death in the mouse utricle preparation. Given that Hsp70 is the most robustly induced Hsp in our system, we examined whether Hsp70 overexpression is sufficient to protect hair cells against aminoglycoside-induced cell death. To address this question, we utilized transgenic mice that constitutively overexpress Hsp70 under the control of the human cytomegalovirus immediate early enhancer (hCMV-IE) and chicken β-actin promoter (Marber et al. 1995). These mice have been shown to be resistant to ischemia in both the heart and brain (Marber et al. 1995; Tsuchiya et al. 2003). Furthermore, Hsp70-overexpressing mice are protected against both damage-induced and age-related dysfunction of skeletal muscles (McArdle et al. 2004). Here, we have shown that Hsp70 overexpression results in inhibition of aminoglycoside-induced hair cell death caused by moderate-to-high doses of neomycin. In addition, as the level of protection provided by heat shock in wild-type utricles is similar to the protective effect of Hsp70 overexpression against a moderate dose of neomycin, it appears that Hsp70 overexpression is sufficient to account for much of the protective effect of heat shock at that same dose. Interestingly, Hsp70 protein levels are significantly lower in Hsp70-overexpressing utricles than in heat shocked wild-type utricles, indicating that mild upregulation of Hsp70 is sufficient to inhibit hair cell death induced by aminoglycosides.
Following in vivo administration, aminoglycoside concentrations in the endolymphatic and perilymphatic fluids are lower than in explant culture models (Harpur and Gonda 1982; Forge and Li 2000; Cunningham et al. 2002, 2004; Ding et al. 2003; Takumida and Anniko 2005; Cunningham and Brandon 2006; Sugahara et al. 2006; Taura et al. 2006). The aminoglycoside concentrations required to induce hair cell death in the adult mouse utricle preparation are consistently in the millimolar range (Cunningham et al. 2002, 2004; Cunningham and Brandon 2006; Sugahara et al. 2006). This concentration range is similar to what has been used by other investigators for examining hair cell death in vestibular explant cultures from adult mammals (Forge and Li 2000; Park et al. 2007) and postnatal mammalian vestibular explants (Quint et al. 1998; Berggren et al. 2003) and organotypic cultures of postnatal mammalian cochlea (Ding et al. 2002; Wei et al. 2005). There are several possible reasons that higher concentrations are required in in vitro systems. First, aminoglycosides have been suggested to enter hair cells through the mechanotransduction channel (Gale et al. 2001; Marcotti et al. 2005), which is likely less active in explant cultures. Secondly, it is conceivable that the process of explanting the utricles may result in significant damage to tip links, again limiting aminoglycoside entry via transduction channels. Thirdly, it is difficult to mimic the clinical scenario of chronic exposure to low doses of aminoglycosides in vitro because explant cultures cannot be maintained in culture for the extended periods of time required to induce damage by chronic aminoglycoside exposure. To overcome this limitation of the in vitro model system, explant cultures are exposed acutely to higher doses of aminoglycosides to induce damage. Studies involving in vitro model systems must therefore be followed up by in vivo experiments to determine whether the in vitro model system recapitulates the in vivo situation.
The use of Hsp70 as a clinical therapy would require a method of inducing Hsp70, either via heat shock, or via pharmaceutical induction of Hsp70. Sugahara et al. (2003) have shown that local hyperthermia can induce Hsp70 in the guinea pig cochlea similarly to whole-body heat stress (Dechesne et al. 1992). Both local and whole-body hyperthermia inhibit hearing loss and noise-induced loss of sensory cells in the inner ear (Yoshida et al. 1999; Sugahara et al. 2003). Geranylgeranylacetone (GGA) is an example of an available therapeutic drug that has been shown to induce Hsps in several systems. GGA is an isoprenoid that is used clinically for the treatment of gastritis and gastric ulcers (Murakami et al. 1981, 1982a, b). GGA induces Hsp70 in a variety of tissues, including the gastric mucosa, heart, liver, brain, and cochlea (Hirakawa et al. 1996; Ooie et al. 2001; Oda et al. 2002; Mikuriya et al. 2005; Sone et al. 2005). In designing a therapy aimed at the prevention of drug-induced hearing loss and/or balance disorders, Hsp70 induction by GGA or other pharmaceutical inducers may represent a rational alternative to induction by local and whole-body heat stress. Interestingly, two recent studies have demonstrated the protective effect of GGA against aminoglycoside-induced vestibular and cochlear damage in vitro (Takumida and Anniko 2005; Sano et al. 2007). Altogether, these data suggest that pharmaceutical induction of Hsps may represent a candidate co-therapy aimed at the inhibition of ototoxic drug-induced hair cell apoptosis.
Here, we present three lines of evidence indicating that Hsp70 is the major mediator underlying the protective effect of heat shock against aminoglycoside-induced hair cell death. First, utricles from Hsp70.1/3 −/− mice lose all of the protective effect of heat shock against aminoglycoside-induced cell death, while this protective effect is observed in wild-type utricles. Second, the neomycin dose–response curve is similar in Hsp70-overexpressing utricles and in heat shocked utricles of CBA mice. Third, Hsp70 overexpression accounts for much of the protective effect of heat shock in wild-type utricles against hair cell death induced by a moderate dose of neomycin. These data indicate that Hsp70 is both necessary for the protective effect of heat shock and that overexpression of Hsp70 provides significant protection against aminoglycoside-induced hair cell death. Taken together, Hsp70 induction may represent a potential clinical therapy against aminoglycoside-induced hearing and balance disorders. Studies are currently underway directed at elucidating the mechanism(s) by which Hsp70 protects hair cells from aminoglycoside-induced death.
The authors gratefully acknowledge Dr. Anna Lysakowski’s guidance in the preparation of utricular sections. This work was supported by NIH DC07613 and by NIH/NCRR extramural research facilities (C06) grants C06 RR015455 and C06 RR14516 from the Extramural Research Facilities Program of the National Center for Research Resources.